This site is intended for healthcare professionals only
LoginRegister
Sanofi earns orphan drug designation for multiple myeloma drugSanofi earns orphan drug designation from USFDA for multiple myeloma drug
Govt sets target to open 25000 Jan Aushadhi Kendras by March 2027: MinisterGovt sets target to open 25000 Jan Aushadhi Kendras by March 2027: Minister
AbbVie seeks USFDA nod for combination regimen of Venclexta, AcalabrutinibAbbVie seeks USFDA nod for combination regimen of Venclexta, Acalabrutinib for previously untreated...
NPPA Approves Separate Price for GSKs New Paracetamol-Phenylephrine SachetNPPA Approves Separate Price for GSK's New Paracetamol-Phenylephrine Sachet
Torrent Pharma Gears Up to Launch Oral, Injectable Semaglutide in 2026 Post Patent Expiry: ReportTorrent Pharma Gears Up to Launch Oral, Injectable Semaglutide in 2026 Post Patent Expiry: Report
Intas Pharma appoints Umesh GuptaIntas Pharma appoints Umesh Gupta as Associate Executive Vice President - Manufacturing Operations
Raid in Paschim Vihar: Counterfeit medicine racket bustedRaid in Paschim Vihar: Counterfeit medicine racket busted
Syngene International appoints Gaurav Kushwaha as new Chief Technology OfficerSyngene International appoints Gaurav Kushwaha as new Chief Technology Officer
NPPA Approves Separate Price for GSKs New Paracetamol-Phenylephrine SachetGSK, Hengrui Pharma to develop up to 12 medicines across Respiratory, Immunology & Inflammation and...
AstraZeneca Imfinzi gets USFDA priority reviewAstraZeneca Imfinzi gets USFDA priority review for resectable early stage gastric, gastroesophageal...
Bristol Myers Squibb, Bain Capital form new biopharmaceutical company - NewCoBristol Myers Squibb, Bain Capital form new biopharmaceutical company - NewCo
Bayer Sevabertinib accepted for review in China for advanced non-small cell lung cancerBayer Sevabertinib accepted for review in China for advanced non-small cell lung cancer
X